Ajay Kumar, Chief Clinical Officer, Hartford HealthCare, Ulysses Wu, MD, Chief Epidemiologist & System Director, Infectious Diseases, Hartford HealthCare and Eric Arlia, Vice President, Pharmacy Services, Hartford HealthCare, say that the FDA has granted Pfizer authorization for their new COVID-19 pill for people ages 12 and up who are at an increased risk of hospitalization.
